Drug intelligence / Profile preview

Proponent Nasal Spray (Nordic Pharma)

Development stage
Unknown
Lead developer
Nordic Pharma
Administration
Intranasal
01

Overview

Proponent Nasal Spray (PSNS) is a medical device developed by Pharma Nordic AS for the treatment of rhinitis medicamentosa (RM), a condition characterized by rebound nasal congestion resulting from the chronic overuse of topical sympathomimetic decongestants such as xylometazoline or oxymetazoline. Proponent is designed to provide symptomatic relief of nasal congestion in adults who are undergoing the weaning process from these addictive alpha-adrenergic agonists. As a medical device, its mechanism of action is primarily physical or mechanical rather than pharmacological, likely involving the cleansing and moisturizing of the nasal mucosa to restore normal physiological function without inducing further rebound effects. It has been evaluated in randomized, double-blind, multicenter clinical trials comparing its efficacy to physiological saline (0.9% sodium chloride).

Brand names
PROPONENT
Other names
Proponent Solution - Nasal Spray
02

Targets

TNFR (TNF receptor family)

Beyond the preview

Go deeper on Proponent Nasal Spray (Nordic Pharma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proponent Nasal Spray (Nordic Pharma).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call